Upstate Medical University News

TAF Impact: Meeting the Dengue Challenge

Adam Waickman has developed a new treatment for dengue that has been shown to neutralize all four serotypes of the virus.

TAF Impact: Revolutionizing Healthcare

Juntao Luo’s platform technology can be customized and applied for severe Covid, immunotherapy cancer treatments and other therapies.

Upstate Startup Wins $50,000 FuzeHub Grant

DUB Biologics is creating a siRNA therapeutic that could prevent corneal scarring and inflammation and revolutionize the treatment of corneal injuries.

Groundbreaking Clinical Trial at Upstate Offers Hope for Epilepsy Patients

The new NRTX-1001 treatment being tested by Neurona Therapeutics implants cells directly into the brain.

Dedicated to Helping the Aging

Sharon Brangman’s interest in helping older patients naturally led her to study the diseases primarily associated with aging; dementia and Alzheimer's.

SUNY Upstate Clinical Trial Leads to RSV Treatment

Dr. Joseph Domachowske developed a first-of-its-kind treatment for RSV at SUNY Upstate, utilizing clinical trials to prove his treatment safe and effective.

Upstate Study Links Ingredient in Sweeteners to Liver Cancer

A team led by SUNY Distinguished Professor Andras Perl studied how mice with a genetic mutation also found in humans progress from cirrhosis to liver cancer.

Patent Awarded for Test to Help Diagnose Concussion

This is the second patent awarded for saliva tests to Quadrant Biosciences and its partners, the SUNY Research Foundation and the Penn State Research Foundation.

$1.8M Federal Grant Funds Study of Fetal Alcohol Syndrome

Upstate Medical University's Eric Olson, will use the funding to test why the wiring of the fetal brain, can be so deeply impacted by exposure to alcohol during development.

University/industry consortium secures patent for Autism Spectrum Disorder diagnostic test

The groundbreaking innovation the result of seven years of research at Upstate Medical University and Penn State College of Medicine.

Startup produces treatment to spur bone growth

Zetagen Therapeutics benefits from its location in the Central New York Biotech Accelerator.

Upstate Medical incubator helps steer biotech breakthroughs to market

The Central New York Biotech Accelerator is one of 17 SUNY business incubators that help to advance innovation and drive economic development throughout NYS.

SUNY research seeks solutions to Alzheimer’s disease

Unchecked, AD cases are expected to reach 16 million by 2050. SUNY researchers are hard at work probing the causes, developing treatments and creating a cure.

Integrating environmental health and medicine

Environmental influences on health care range from weather pattern changes to the increasing use of nanomaterials in consumer products.

SUNY startup developing technology to help patients better tolerate chemotherapy

Upstate professor William Kerr is exploring how manipulating a gene could significantly improve blood cell recovery following chemotherapy.

Leading research in next-generation computing and communication

SUNY researchers are at the leading edge of rapid developments in materials, devices, systems, manufacturing processes and the engineering of computers.

A leader in global healthcare research and education

Working with global partners, researchers on SUNY’s campuses are making a difference in the lives of people around the world.

Quadrant Biosciences awarded $2M NIH grant to support “game changing” test

SUNY Upstate researcher Frank Middleton says a biomarker found in saliva may lead to earlier diagnosis of autism.

Cultivating an entrepreneurial mindset

SUNY ZAP! helps SUNY’s scientists and engineers take research from the lab to the marketplace.

SUNY brings broad expertise to University Climate Change Coalition

SUNY is taking a leadership role to mitigate the causes of climate change and reduce vulnerability to the environmental challenges caused by a warming Earth.

Teaming up to target antibiotic resistance

Collegiality in the SUNY system leads to new lines of research and new approaches to antibiotic development.

Attacking Alzheimer ’s disease

Researchers across the SUNY campuses are attacking the problem of Alzheimer’s from every possible angle.

SUNY on the front lines in the battle with substance abuse and addiction

SUNY employing its talented faculty and leading-edge facilities to approach this public health crisis from several angles.

Open wide and say ‘aha!’

SUNY Upstate urologist looks to patient’s mouths for help repairing urethral strictures.

Start-up to develop anti-obesity treatments using compounds licensed from Upstate

SUNY Technology Accelerator Fund investment advances promising therapy.

Searching for roots in disease

An Upstate Medical University professor of medicine investigates retrovirus and other causes of disease in humans.

TAF investment will be used to advance a new concussion assessment tool

The new set of cognitive tests will help doctors and clinicians properly diagnose and manage concussions.

Summer program gives undergraduates a broader research opportunity

SURF requires each fellow to think a project through from beginning to end, formulating a hypothesis and developing a theme.

Upstate awarded nearly $200K for Zika virus research

The NSF-funded project will build on Anna Stewart Ibarra’s studies into the ecology of infectious diseases.

With a single molecule, an opportunity to help millions of people

New technology that could help patients regrow blood cells after chemotherapy, radiation, or bone marrow transplants may also treat obesity.

Upstate partners with U.S. Army to develop dengue virus vaccine

Upstate was selected to partner in this effort because of its clinical trial center and expertise in dengue disease and human infection trials.

Researchers identify subtype of lethal prostate cancer

Findings may aid in the development of drugs to suppress tumors or provide more precision in the treatment of aggressive cancers.

SUNY team targets nearsightedness

Researchers are working to open our eyes to a new understanding of what drives myopia onset and progression, with a goal of uncovering new treatments.